Clinical Trial Update: Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) [Phase 3]

View source ↗

Summary

Phase 3 trial update for the FASTR-II study evaluating fluid management with the Reprieve System in acute decompensated heart failure; trial is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• Reprieve System

Snippet

Sponsor: Reprieve Cardiovascular, Inc | Conditions: Acute Decompensated Heart Failure | Phase 3 | Status: RECRUITING